Journal of Antimicrobial Chemotherapy (2001) 47, 345-348
© 2001 The British Society for Antimicrobial Chemotherapy
Brief report |
Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada
a Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec; b Mount Sinai Hospital, University of Toronto, Toronto, Ontario; c Groupe de Recherche sur les Anti-Microbiens (GRAM), Hôpital Maisonneuve-Rosemont, 5415 L'Assomption, Montreal, Quebec, Canada H1T 2M4
Resistance to macrolides among group A streptococci is an increasing problem worldwide. We examined 496 strains phenotypically and genotypically for resistance to erythromycin and clindamycin. Strains were isolated in five different geographical areas representing about 45% of the total Quebec population. The overall resistance rate was 4.6% but varied from 0% in rural areas to 9.4% in Montreal. Of the 23 strains showing resistance to erythromycin, 15 (65%) had an identical pulsed-field gel electrophoresis pattern, were of serotype M28T28 and harboured the erm(TR) gene, suggesting the spread of a single clone. Of the remaining eight strains, two strains had the erm(B) gene, five had the mef gene and one with a different serotype also had the erm(TR) gene.
* Corresponding author. Hôpital Maisonneuve-Rosemont, 5415 L'Assomption, Montreal, Quebec, Canada H1T 2M4. Tel: +1-514-252-3817; Fax: +1-514-252-3898; E-mail: weisscan{at}aol.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Littauer, D. A. Caugant, M. Sangvik, E. A. Hoiby, A. Sundsfjord, G. S. Simonsen, and the Norwegian Macrolide Study Group Macrolide-Resistant Streptococcus pyogenes in Norway: Population Structure and Resistance Determinants. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1896 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Green, C. Allen, J. Bradley, B. Dashefsky, J. R. Gilsdorf, M. J. Marcon, G. E. Schutze, C. Smith, E. Walter, J. M. Martin, et al. In Vitro Activity of Telithromycin against Macrolide-Susceptible and Macrolide-Resistant Pharyngeal Isolates of Group A Streptococci in the United States Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2487 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Erdem, J. Ford, D. Johnson, L. Abe, K. Yamaga, and E. Kaplan Erythromycin-Resistant Group A Streptococcal Isolates Collected between 2000 and 2005 in Oahu, Hawaii, and Their emm Types J. Clin. Microbiol., May 1, 2005; 43(5): 2497 - 2499. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF] |
||||
![]() |
G. J. Tyrrell, M. Lovgren, B. Kress, and K. Grimsrud Invasive Group A Streptococcal Disease in Alberta, Canada (2000 to 2002) J. Clin. Microbiol., April 1, 2005; 43(4): 1678 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Desjardins, K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results J. Clin. Microbiol., December 1, 2004; 42(12): 5620 - 5623. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bingen, P. Bidet, L. Mihaila-Amrouche, C. Doit, S. Forcet, N. Brahimi, A. Bouvet, and R. Cohen Emergence of Macrolide-Resistant Streptococcus pyogenes Strains in French Children Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3559 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hasenbein, J. E. Warner, K. G. Lambert, S. E. Cole, A. B. Onderdonk, and A. J. McAdam Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area J. Clin. Microbiol., April 1, 2004; 42(4): 1559 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Portillo, M. J. Gastanares, F. Ruiz-Larrea, and C. Torres Clonal diversity among erythromycin-resistant {beta}-haemolytic Streptococcus isolates in La Rioja, Spain J. Antimicrob. Chemother., September 1, 2003; 52(3): 485 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-R. Hsueh, L.-J. Teng, C.-M. Lee, W.-K. Huang, T.-L. Wu, J.-H. Wan, D. Yang, J.-M. Shyr, Y.-C. Chuang, J.-J. Yan, et al. Telithromycin and Quinupristin-Dalfopristin Resistance in Clinical Isolates of Streptococcus pyogenes: SMART Program 2001 Data Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2152 - 2157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Katz, A. J. McGeer, C. L. Duncan, A. Ashi-Sulaiman, B. M. Willey, A. Sarabia, J. McCann, S. Pong-Porter, Y. Rzayev, J. S. de Azavedo, et al. Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001 Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2370 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Ho, D. R. Johnson, A. W. Y. Yue, D. N. C. Tsang, T. L. Que, B. Beall, and E. L. Kaplan Epidemiologic Analysis of Invasive and Noninvasive Group A Streptococcal Isolates in Hong Kong J. Clin. Microbiol., March 1, 2003; 41(3): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dicuonzo, E. Fiscarelli, G. Gherardi, G. Lorino, F. Battistoni, S. Landi, M. De Cesaris, T. Petitti, and B. Beall Erythromycin-Resistant Pharyngeal Isolates of Streptococcus pyogenes Recovered in Italy Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3987 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Detcheva, R. R. Facklam, and B. Beall Erythromycin-Resistant Group A Streptococcal Isolates Recovered in Sofia, Bulgaria, from 1995 to 2001 J. Clin. Microbiol., October 1, 2002; 40(10): 3831 - 3834. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963. [Abstract] [Full Text] [PDF] |
||||


